✦ LIBER ✦

Atherosclerosis and cardiovascular risk reduction with PPAR agonists

✍ Scribed by Johanna Kuusisto; Laura Andrulionyte; Markku Laakso

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PPARγ agonists and coronary atherosclero

✍ Melanie S. Sulistio; Adrienne Zion; Nandish Thukral; Robert Chilton 📂 Article 📅 2008 🏛 Current Science Inc. 🌐 English ⚖ 561 KB

Cardiovascular risk and atherosclerosis

✍ Jiri Frohlich; Ahmad Al-Sarraf 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 142 KB

PPAR agonists for the treatment of cardi

✍ J. P. H. Wilding 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 713 KB

Assessment of subclinical atherosclerosi

✍ R. Michael BENITEZ; Robert A. Vogel 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 990 KB

Salt reduction and cardiovascular risk

✍ Alderman, Michael H 📂 Article 📅 1999 🏛 Nature Publishing Group 🌐 English ⚖ 19 KB

Increased atherosclerosis following trea

✍ Anna C. Calkin; Terri J. Allen; Markus Lassila; Christos Tikellis; Karin A. Jand 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 425 KB